Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Revenue

Pharmaniaga Berhad had revenue of 1.04B MYR in the quarter ending June 30, 2026, with 12.32% growth. This brings the company's total for the last twelve months to 4.17B, up 5.75% year-over-year. In the year 2025, Pharmaniaga Berhad had annual revenue of 3.93B with 4.48% growth. That makes Pharmaniaga Berhad the 7,522nd largest company in the world by revenue and 67th in Malaysia.

• Revenue (ttm): 4.17B
• Revenue Growth: +5.75%
• P/S Ratio: 0.24
• Revenue / Employee: 1.19M
• Employees: 3,502
• Market Cap: 1.00B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Malaysia - Logistics and Distribution 2.81B 65.8%
• Indonesia - Manufacturing & distribution 1.12B 26.1%
• Malaysia - Manufacturing 342.89M 8.0%

By Geography

Chart

• Malaysia 2.80B 71.4%
• Indonesia 1.12B 28.4%
• Other Countries 8.44M 0.2%

Fiscal year ended Dec 31, 2025 See the full Pharmaniaga Berhad breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.93B	168.27M	4.48%
Dec 31, 2024	3.76B	355.00M	10.43%
Dec 31, 2023	3.40B	-76.45M	-2.20%
Dec 31, 2022	3.48B	-1.33B	-27.71%
Dec 31, 2021	4.82B	2.09B	76.69%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error